City

Bethesda (1)

Petach-Tikva (1)

Condition

Velocardiofacial Syndrome (2)

22q11.2 Syndrome (1)

DiGeorge Syndrome (1)

Fragile X Syndrome (1)

Williams Syndrome (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

National Institute of Mental Health (NIMH) (1)

The Chaim Sheba Medical Center (1)

Collaborator

Intervention

methylphenidate, fluoxetin, risperidone (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

velocardiofacial syndrome

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Velocardiofacial Syndrome, Williams Syndrome, Fragile X Syndrome Trial in Petach-Tikva (methylphenidate, fluoxetin, risperidone)

Recruiting

Velocardiofacial Syndrome
+2 more

methylphenidate, fluoxetin, risperidone

Petach-Tikva, Israel

Schneider Children's Mediac Center of Israel

Mar 8, 2022

Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study

Completed

DiGeorge Syndrome
+2 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jun 30, 2017